REG - Target H'care REIT - Directorate Change

Target Healthcare ReitAnnouncement

07/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221207:nRSG7964Ia&default-theme=true

RNS Number : 7964I  Target Healthcare REIT PLC  07 December 2022

To:                    RNS

Date:                7 December 2022

Company:        Target Healthcare REIT plc

LEI:                  213800RXPY9WULUSBC04

Subject:           Directorate Change

 

 

 

Directorate Change

 

The Board of Directors of Target Healthcare REIT plc ('the Company') is
pleased to announce the appointment of Mr Michael Brodtman as an independent
non-executive Director of the Company with effect from 1 January 2023.

 

Mr Brodtman has extensive knowledge of the property sector. He worked for
global property advisers CBRE for over 40 years, retiring as chairman of the
UK Advisory division in June 2022. He led the firm's Valuation department for
over 20 years, and served on its Executive Board and Operating Committee,
respectively responsible for strategic direction and day-to-day management.

 

He is a Fellow of the Royal Institution of Chartered Surveyors and has been
extensively involved with the RICS throughout his professional career. He was
formerly a member of the Policy Committee of the British Property Federation,
the RICS Global Valuation Professional Board and the Bank of England
Commercial Property Forum.

 

Mr Brodtman will also become a non-executive Director of Grainger plc with
effect from 1 January 2023 and has further Board experience as a former
non-executive director of Investment Property Databank and housing association
Places for People. He is keenly interested in the healthcare sector, with
relevant experience from his role as a Trustee of Jewish Care, which provides
health and social care services for London's Jewish Community, including ten
care homes with some 500 residents.

 

At the date of his appointment, Mr Brodtman holds 24,210 Ordinary Shares in
the Company.

 

There is no further information required to be disclosed pursuant to paragraph
9.6.13 R of the Listing Rules in relation to this appointment.

 

 

All Enquiries:

Kenneth MacKenzie, Gordon Bland

Target Fund Managers Limited

01786 845 912

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABSBDDUXGDGDL